The Europe Ocular Trauma Devices Market would witness market growth of 6.6% CAGR during the forecast period (2022-2028).
The iris' microvasculatures are generally harmed when there is a hyphema. In such cases, maintaining an upright posture, Eye protection, and prompt ophthalmologist referral are all part of the initial therapy. Additionally, in prominent cases of ocular trauma, a common symptom of vitreous hemorrhage is an acute vision which happens as a result of fundus opacification.
The risk of vitreous bleeding following trauma is increased by preexisting retinopathy in the presence of sickle cell disease or diabetes. After a retinal break, the neurosensory retina may subsequently separate from the surrounding retinal pigment epithelium, leading to a rhegmatogenous retinal detachment. In such instances, in order to maintain vision, surgery must be performed right away.
Corneal abrasions are defined as superficial wounds that can range in size from minor epithelial imperfections that heal on their own to visually noticeable lesions that progress to scarring, infection, and/or astigmatism. On the other hand, corneal incisions are a form of open globe injury that needs immediate surgical treatment. Pupil peaking, iris clogging, and anterior chamber flattening are frequently present in patients with corneal lacerations.
In Europe, vision loss affects one in thirty persons on average, and the number of partially sighted people outnumbers the number of blind people by a ratio of four. According to the European Blind Organization (EBU), vision loss affects one in three seniors over the age of 65. According to EBU estimates, there are 30 million visually impaired people in the region. Similarly, through a one-year study on patients in Western Infirmary Casualty Department and Glasgow Eye Infirmary, it was found that about 69.9% of eye injuries usually occurred at work.
The Germany market dominated the Europe Ocular Trauma Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $355.6 Million by 2028. The UK market is anticipated to grow at a CAGR of 5.7% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.3% during (2022 - 2028).
Based on End-Use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on Type, the market is segmented into Implants, Instruments, and Disposables. Based on Indication, the market is segmented into Blunt Trauma, Chemical Trauma, and Sharp Trauma. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Ocular Trauma Devices Market will Hit $5.3 Billion by 2028, at a CAGR of 6.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Glaukos Corporation, Alcon, Inc., EssilorLuxottica SA (Essilor Instruments USA), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Carl Zeiss AG, Topcon Corporation, CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Hoya Corporation.
By End-Use
By Type
By Indication
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 